Inactivating viruses from biopharmaceutical source materials can be achieved with detergents. However, the frequently used detergent Triton X-100 is ecotoxic and must be replaced with eco-friendly alternatives.
Inactivating viruses from biopharmaceutical source materials can be achieved with detergents. However, the frequently used detergent Triton X-100 is ecotoxic and must be replaced with eco-friendly alternatives.
In 2019, CRISPR gene-editing therapy was used for the first time to treat sickle cell disease.
Protein-protected metal nanoclusters have excellent biocompatibility and have received considerable attention as a luminescent probe in a number of fields such as biosensing, bioimaging, and imaging-guided therapy.
“This work opens new avenues for material scientists and biologists to mimic in the lab the structure of living tissues and to upscale the production of engineered constructs.” ~ Dr. Riccardo Levato and Prof. Chris Moser.
Pharmacists‐led interventions can significantly reduce medical risk factors, supporting the involvement of pharmacists as healthcare providers in managing patients with hypertension, diabetes and dyslipidaemia.
Unraveling the mystery of viral evolution, scientists discover a similarity between hepatitis A and the Triatoma virus that infects blood-sucking kissing bugs.
A new use for the revolutionary gene-splicing tool. This new “Electrochemical CRISPR” can quickly and accurately identify viral biomarkers for a range of diseases, including HPV and Parvovirus.
Somewhere in a jumble of protein building blocks may lie the key to unlocking the next generation of therapeutics to improve human health.
The ways astronauts prep for spaceflight could benefit cancer patients, researchers say.
Researchers engineer natural killer cells to specifically target cancer cells.